Indexed with PubMed and Science Citation Index (E) 
Users online: 1184 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
   Next article
   Previous article 
   Table of Contents
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (90 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article
   Article Tables

 Article Access Statistics
    PDF Downloaded246    
    Comments [Add]    
    Cited by others 9    

Recommend this journal


Year : 2009  |  Volume : 75  |  Issue : 2  |  Page : 187-189

Effect of warfarin on chronic idiopathic urticaria

1 Department of Pulmonology, JSS Medical College and Hospital, Mysore, India
2 Department of Allergy, University of Colorado Health Sciences, Mysore, India
3 Department of Allergy, Allergy Asthma and Chest Center, Mysore, India

Correspondence Address:
P A Mahesh
Department of Pulmonology, JSS Medical College, 1397, 4th Cross, Krishnamurthypuram, Mysore-570 004, Karnataka
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0378-6323.48673

Rights and Permissions

How to cite this article:
Mahesh P A, Pudupakkam VK, Holla AD, Dande T. Effect of warfarin on chronic idiopathic urticaria. Indian J Dermatol Venereol Leprol 2009;75:187-9

How to cite this URL:
Mahesh P A, Pudupakkam VK, Holla AD, Dande T. Effect of warfarin on chronic idiopathic urticaria. Indian J Dermatol Venereol Leprol [serial online] 2009 [cited 2017 Dec 16];75:187-9. Available from: http://www.ijdvl.com/text.asp?2009/75/2/187/48673


Urticarias unresponsive to antihistamines are frustrating for both physicians and patients. In severe cases, steroids or cyclosporine may be needed. [1] This retrospective observation highlights the potential of warfarin in managing chronic idiopathic urticaria (CIU).

Five patients with CIU needed daily oral steroids for more than 3 weeks, with symptom recurrence on tapering steroids at least twice. Literature search for drugs that could be useful identified warfarin, which had shown benefit in managing CIU unresponsive to antihistamines. [2] A detailed history was followed by an autologous serum skin test (ASST) and an autologous plasma skin test (APST). [3] None had any pre-disposition to bleeding nor were on medications that interacted with warfarin. Baseline coagulation parameters were normal. Warfarin was initiated at 1 mg and increased by 1 mg weekly, with adequate monitoring of prothrombin time (PT) [Table 1]. Dosage was maintained in symptom-free patients with tapering of steroids. Steroids were tapered every 3 days. Response was evaluated by physician examination every week and was graded as "none," "partial" and "total." "None" included no difference in the number, duration and size of wheals and severity of itching. Lesser extent of urticaria in the preceding week was considered "partial" and having no urticaria in the preceding week, "total." Demographic and clinical characteristics are summarised in [Table 1]. All five cases had positive APST and four had positive ASST. In four cases, steroids could be withdrawn completely. Warfarin was used for 2-5 months. In three patients, there was no recurrence of CIU after warfarin withdrawal. Two patients, with onset of clinical response within 2 weeks, had "total" response, possibly due to warfarin. Two had "partial" response at 2 months, in whom it was difficult to differentiate the effect of warfarin from steroids. In one, no reduction in clinical symptoms or steroids was possible.

We are aware of only one communication regarding the use of warfarin in difficult-to-treat autoreactive CIU. In the study by Parslew et al, [2] APST was not performed and patients were ASST negative. In our patients, APST was positive in all and ASST in four and the international normalized ratio (INR) was below 2 in all patients, whereas Parslew et al [2] maintained an INR between 2 and 2.5 to obtain benefit from warfarin. Warfarin dosage of 2-5 mg was similar to the study by Parslew et al (2-6 mg). The mechanism of action of warfarin is by suppression of thrombin, a potent mast cell degranulator, [4] and proteins in the coagulation cascade (Factors VII, IX and X). [3] Asero et al demonstrated involvement of the extrinsic coagulation pathway in CIU [5] thus providing the rationale for anticoagulant use.

Monitoring patients with PT repeatedly is important as the major adverse effect is bleeding, especially with an INR of more than 3. Some drugs potentiating warfarin include fluconazole, omeprazole, metronidazole, acetaminophen, cotrimoxazole and antiretroviral drugs like protease inhibitors. Caution should be exercised in patients using other antiplatelet drugs like aspirin or non-steroidal anti-inflammatory drugs.

Prospective long-term studies with adequate design are required to place warfarin appropriately in the management of CIU. Characteristics of subjects responsive to warfarin as compared with non-responders, monitoring D-dimer levels and risk-benefit ratio need elucidation. Warfarin may be useful in autoreactive CIU. Warfarin may be considered in subjects with CIU with coexisting diseases needing long-term warfarin, like deep vein thrombosis, atrial fibrillation or recurrent pulmonary embolism.

  References Top

1.Tedeschi A, Airaghi L, Lorini M, Asero R. Chronic urticaria: A role for newer immunomodulatory drugs? Am J Clin Dermatol 2003;4:297-305.   Back to cited text no. 1  [PUBMED]  
2.Parslew R, Pryce D, Ashworth J, Friedmann PS. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy 2000;30:1161-5.   Back to cited text no. 2  [PUBMED]  [FULLTEXT]
3.Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006;117:1113-7.   Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Duvall LA, Boackle RJ, King RG. Warfarin sodium therapy for chronic urticaria and angioedema. South Med J 1986;79:389.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]
5.Asero R, Tedeschi A, Coppola R, Griffini S, Paparella P, Riboldi P, et al . Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol 2007;119:705-10.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]


  [Table 1]

This article has been cited by
1 Activation of coagulation in chronic urticaria in relation to disease severity and activity
M.N. Farres,M. Refaat,N.A. Melek,E.E. Ahmed,M.G. Shamseldine,N.A. Arafa
Allergologia et Immunopathologia. 2015; 43(2): 162
[Pubmed] | [DOI]
2 The diagnosis and management of acute and chronic urticaria: 2014 update
Jonathan A. Bernstein,David M. Lang,David A. Khan,Timothy Craig,David Dreyfus,Fred Hsieh,Javed Sheikh,David Weldon,Bruce Zuraw,David I. Bernstein,Joann Blessing-Moore,Linda Cox,Richard A. Nicklas,John Oppenheimer,Jay M. Portnoy,Christopher R. Randolph,Diane E. Schuller,Sheldon L. Spector,Stephen A. Tilles,Dana Wallace
Journal of Allergy and Clinical Immunology. 2014; 133(5): 1270
[Pubmed] | [DOI]
3 Chronic Spontaneous Urticaria: the Emerging Role of Coagulation
Angelo V. Marzano,Alberto Tedeschi,Claudia Menicanti,Riccardo Asero,Carlo Crosti,Massimo Cugno
Current Dermatology Reports. 2013; 2(1): 18
[Pubmed] | [DOI]
4 Management of chronic urticaria in Asia: 2010 AADV consensus guidelines
Steven K.W. Chow
Asia Pacific Allergy. 2012; 2(2): 149
[VIEW] | [DOI]
5 Pharmacological rationale for the treatment of chronic urticaria with second-generation non-sedating antihistamines at higher-than-standard doses : Second-generation antihistamines at higher doses
T. Zuberbier
Journal of the European Academy of Dermatology and Venereology. 2012; 26(1): 9
[VIEW] | [DOI]
6 Class action of oral coumarins in the treatment of a patient with chronic spontaneous urticaria and delayed-pressure urticaria : Class action of coumarins in chronic spontaneous urticaria
V. Samarasinghe, A. M. Marsland
Clinical and Experimental Dermatology. 2012; : no
[VIEW] | [DOI]
7 Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications
Massimo Cugno, Angelo V. Marzano, Riccardo Asero, Alberto Tedeschi
Internal and Emergency Medicine. 2010; 5(2): 97
[VIEW] | [DOI]
8 Activation of blood coagulation in autoimmune skin disorders
Cugno, M., Tedeschi, A., Crosti, C., Marzano, A.V.
Expert Review of Clinical Immunology. 2009; 5(5): 605-613
9 Activation of blood coagulation in autoimmune skin disorders
Massimo Cugno,Alberto Tedeschi,Carlo Crosti,Angelo V Marzano
Expert Review of Clinical Immunology. 2009; 5(5): 605
[Pubmed] | [DOI]


Print this article  Email this article
Previous article Next article


Online since 15th March '04
Published by Wolters Kluwer - Medknow